0
Original Research: NEOPLASTIC DISEASES |

S-Adenosylmethionine as a Biomarker for the Early Detection of Lung Cancer*

Alissa K. Greenberg, MD; Binaya Rimal, MD; Kevin Felner, MD; Subooha Zafar, MD; Jerry Hung, MD; Ellen Eylers, MSN, RN, MPH; Brendan Phalan, BA; Meng Zhang, MS; Judith D. Goldberg, ScD; Bernard Crawford, MD, FCCP; William N. Rom, MD, MPH, FCCP; David Naidich, MD, FCCP; Salim Merali, PhD
Author and Funding Information

Affiliations: *From the Division of Pulmonary and Critical Care Medicine, Department of Medicine (Drs. Greenberg, Rimal, Felner, Zafar, Hung, and Rom, Ms. Eylers, and Mr. Phalan), Division of Biostatistics, Department of Environmental Medicine (Ms. Zhang and Dr. Goldberg), and Departments of Cardiothoracic Surgery (Dr. Crawford), Radiology (Dr. Naidich), and Medical and Molecular Parasitology (Dr. Merali), New York University School of Medicine, New York, NY.,  Currently at the Department of Biochemistry, Temple University, Philadelphia, PA.

Correspondence to: William N. Rom, MD, MPH, FCCP, Division of Pulmonary and Critical Care Medicine, Department of Medicine, NYU School of Medicine, 550 First Ave, New York, NY 10016; e-mail: William.rom@med.nyu.edu



Chest. 2007;132(4):1247-1252. doi:10.1378/chest.07-0622
Text Size: A A A
Published online

Background: S-Adenosylmethionine (AdoMet) is a major methyl donor for transmethylation reactions and propylamine donor for the biosynthesis of polyamines in biological systems, and therefore may play a role in lung cancer development. We hypothesized that AdoMet levels were elevated in patients with lung cancer and may prove useful as a biomarker for early lung cancer.

Methods: High-performance liquid chromatography was used to analyze plasma AdoMet levels in triplicate samples from 68 patients. This included 13 patients with lung cancer, 33 smokers with benign lung disease, and 22 healthy nonsmokers. The three groups of subjects were compared with respect to the distribution of demographic and disease characteristics and AdoMet levels. Distributions were examined using summary statistics and box plots, and nonparametric analysis of variance procedures.

Results: Serum AdoMet levels were elevated in patients with lung cancer as compared to smokers with benign lung disorders and healthy nonsmokers. There were no significant correlations between AdoMet levels and tumor cell types, nodule size, or other demographic variables.

Conclusions: Our data demonstrate that plasma levels of AdoMet are significantly elevated in patients with lung cancer. Plasma AdoMet levels may prove to be a useful tool for the diagnosis of early lung cancer, in combination with chest CT.

Registered at: clinicaltrials.gov (NCT00301119).

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
Screening for Lung Cancer*: A Review of the Current Literature
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543